Global Upstream Bioprocessing Market
Market Size in USD Billion
CAGR :
% 
 Forecast Period |
2022 –2029 |
 Market Size (Base Year) |
USD 8,391.22 Million |
 Market Size (Forecast Year) |
USD 14,256.78 Million |
 CAGR |
% |
| Major Markets Players |
Global Upstream Bioprocessing Market, By Product (Bioreactors/Fermenters, Cell Culture Products, Filters, Bioreactors Accessories, Bags and Containers and Others), Workflow (Media Preparation, Cell Culture and Cell Separation), Use Type (Multi-Use and Single-Use), Mode (In-House and Outsourced) – Industry Trends and Forecast to 2029
Market Analysis and Size
The rising productivity of cell lines has knowingly enhanced the performance of upstream processing with low cost and high process reproducibility. The first step in the bioprocess is upstream bioprocessing, which is used to generate cell lines and cultivate them in order to grow the cells by harvesting.
Data Bridge Market Research analyses that the upstream bioprocessing market which was USD 8,391.22 million in 2021, would rocket up to USD 14256.78 million by 2029, and is expected to undergo a CAGR of 6.85% during the forecast period 2022 to 2029. In addition to the market insights such as market value, growth rate, market segments, geographical coverage, market players, and market scenario, the market report curated by the Data Bridge Market Research team also includes in-depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.
Report Scope and Market Segmentation
|
Report Metric |
Details |
|
Forecast Period |
2022 to 2029 |
|
Base Year |
2021 |
|
Historic Years |
2020 (Customizable to 2014 - 2019) |
|
Quantitative Units |
Revenue in USD Million, Volumes in Units, Pricing in USD |
|
Segments Covered |
Product (Bioreactors/Fermenters, Cell Culture Products, Filters, Bioreactors Accessories, Bags and Containers and Others), Workflow (Media Preparation, Cell Culture and Cell Separation), Use Type (Multi-Use and Single-Use), Mode (In-House and Outsourced) |
|
Countries Covered |
U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America |
|
Market Players Covered |
Thermo Fisher Scientific, Inc. (U.S.), General Electric (U.S.), Merck KGaA (Germany), Corning Incorporated (U.S.), Sartorius AG (Germany), Eppendorf SE (Germany), Lonza (Switzerland), PBS Biotech, Inc. (U.S.), Sartorius CellGenix GmbH (Germany), Boehringer Ingelheim International GmbH (Germany), Samsung Biologics (South Korea), Patheon N.V (U.S.), AGC Biologics (Denmark), Danaher (U.S.), Hash Biotech Labs (India) |
|
Market Opportunities |
|
Market Definition
The production of biopharmaceuticals, also referred to as bioprocessing, is a bioprocess engineering application utilized in the culture of therapeutic cells. End products from bioprocessing have a high value and are utilized to achieve particular goals. Upstream and downstream biopharmaceutical manufacturing are the two types of processes utilized in the production of biopharmaceuticals.
Upstream Bioprocessing Market Dynamics
Drivers
- Rise in chronic disease prevalence
The rise in chronic disease prevalence, more effective treatments using cutting-edge technology and high-quality biologic pharmaceuticals are being produced. Due to these causes, the market for upstream bioprocessing is expanding and upstream processing equipment consumption has expanded. A few other key factors for the expansion of the upstream bioprocessing market are drug development, antibody manufacturing, an increase in the need for cell therapy research.
- Increase in research into the production of biosimilar
The market for upstream bioprocessing is being pushed by an increase in research into the production of biosimilars/biomolecules, monoclonal antibodies, and tiny therapeutic peptides. The demand for process improvement and clean, secure, and effective biomolecule production fuels the market's expansion.
- Research and development activities
Growing biosimilars and biomolecule research and development is a key element fuelling the global market expansion. Globally, the prevalence of chronic diseases is rising, which is anticipated to fuel the global market's expansion in the future.
Opportunities
The usual transition from simple stainless-steel bioreactors to single-use products has prompted manufacturing advantages for upstream applications. Additionally, market competitors are concentrating on cumulative manufacturing of single-use technology due to the growing usage of this technology. For instance, Sartoius Sedium Biotech was chosen by Abzena Company, a biopharmaceutical manufacturer, to develop its Bristol-based production facility for single-use format. This element is therefore anticipated to increase the upstream bioprocessing market applicability in the near future.
Restraints/Challenges
- High cost
The high cost of processing unit setup and maintenance would be a barrier to the expansion of the upstream bioprocessing market during the forecast period.
This upstream bioprocessing market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the upstream bioprocessing market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.
Global Upstream Bioprocessing Market Scope
The upstream bioprocessing market is segmented on the basis of product, workflow, use type, mode. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.
Product
- Bioreactors/Fermenters
- Cell Culture Products
- Filters
- Bioreactors Accessories
- Bags and Containers
- Others
Workflow
- Media Preparation
- Cell Culture
- Cell Separation
Use type
- Multi-Use
- Single-Use
Mode
- In-house
- Outsourced
Upstream Bioprocessing Market Regional Analysis/Insights
The upstream bioprocessing market is analysed and market size insights and trends are provided by country, product, workflow, use type, mode as referenced above.
The countries covered in the upstream bioprocessing market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.
North America is dominating the upstream bioprocessing market due to the largest upstream bioprocessing market share.
Asia-Pacific will register highest growth rate for upstream bioprocessing market due to increasing number of players focusing on emerging market growth potential.
The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points like down-stream and upstream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.
Competitive Landscape and Upstream Bioprocessing Market Share Analysis
The upstream bioprocessing market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to upstream bioprocessing market.
Some of the major players operating in the upstream bioprocessing market are:
- Thermo Fisher Scientific, Inc. (U.S.)
- General Electric (U.S.)
- Merck KGaA (Germany)
- Corning Incorporated (U.S.)
- Sartorius AG (Germany)
- Eppendorf SE (Germany)
- Lonza (Switzerland)
- PBS Biotech, Inc. (U.S.)
- Sartorius CellGenix GmbH (Germany)
- Boehringer Ingelheim International GmbH (Germany)
- Samsung Biologics (South Korea)
- Patheon N.V (U.S.)
- AGC Biologics (Denmark)
- Danaher (U.S.)
- Hash Biotech Labs (India)
SKU-
Get online access to the report on the World's First Market Intelligence Cloud
- Interactive Data Analysis Dashboard
- Company Analysis Dashboard for high growth potential opportunities
- Research Analyst Access for customization & queries
- Competitor Analysis with Interactive dashboard
- Latest News, Updates & Trend analysis
- Harness the Power of Benchmark Analysis for Comprehensive Competitor Tracking
Research Methodology
Data collection and base year analysis are done using data collection modules with large sample sizes. The stage includes obtaining market information or related data through various sources and strategies. It includes examining and planning all the data acquired from the past in advance. It likewise envelops the examination of information inconsistencies seen across different information sources. The market data is analysed and estimated using market statistical and coherent models. Also, market share analysis and key trend analysis are the major success factors in the market report. To know more, please request an analyst call or drop down your inquiry.
The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market and primary (industry expert) validation. Data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Patent Analysis, Pricing Analysis, Company Market Share Analysis, Standards of Measurement, Global versus Regional and Vendor Share Analysis. To know more about the research methodology, drop in an inquiry to speak to our industry experts.
Customization Available
Data Bridge Market Research is a leader in advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customized to include price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), clinical trial results data, literature review, refurbished market and product base analysis. Market analysis of target competitors can be analyzed from technology-based analysis to market portfolio strategies. We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you data in crude raw excel files pivot tables (Fact book) or can assist you in creating presentations from the data sets available in the report.
